European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.

PURPOSE To derive recommendations for routine practice and clinical trials for techniques used in high-dose, high-precision thoracic radiotherapy for lung cancer. METHODS A literature search was performed to identify published articles considered both clinically relevant and practical to use. Recommendations were categorized under the following headings: patient selection, patient positioning and immobilization, tumor motion, computed tomography and [18F]fluorodeoxyglucose-positron emission technology scanning, generating target volumes, radiotherapy treatment planning, treatment delivery, and scoring of response and toxicity. The American College of Chest Physicians grading of recommendations was used. RESULTS Recommendations were identified for each of the recommendation categories. Although most of the recommended techniques have not been evaluated in multicenter clinical trials, their use in high-precision thoracic radiotherapy and stereotactic body radiotherapy (SBRT) appears to be justified on the basis of available evidence. CONCLUSION Recommendations to facilitate the clinical implementation of high-precision conformal radiotherapy and SBRT for lung tumors were identified from the literature. Some techniques that are considered investigational at present were also highlighted.

[1]  D. de Ruysscher,et al.  Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy. , 2012, Cancer treatment reviews.

[2]  Jinzhong Yang,et al.  Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[3]  Hans-Ulrich Kauczor,et al.  MRI of the lung: state of the art. , 2012, Diagnostic and interventional radiology.

[4]  Philippe Giraud,et al.  Respiratory Gating Techniques for Optimization of Lung Cancer Radiotherapy , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  Anton Mans,et al.  Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques. , 2011, International journal of radiation oncology, biology, physics.

[6]  C. Le Péchoux,et al.  Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. , 2011, The oncologist.

[7]  P. Lambin,et al.  Volume or position changes of primary lung tumor during (chemo-)radiotherapy cannot be used as a surrogate for mediastinal lymph node changes: the case for optimal mediastinal lymph node imaging during radiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[8]  Geoffrey D. Hugo,et al.  Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[9]  Matthias Guckenberger,et al.  Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[10]  J. Petersen,et al.  Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung , 2010, Acta oncologica.

[11]  Lone Hoffmann,et al.  Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients , 2010, Acta oncologica.

[12]  J. Sonke,et al.  Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters. , 2010, International journal of radiation oncology, biology, physics.

[13]  P. Lambin,et al.  Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. , 2010, International journal of radiation oncology, biology, physics.

[14]  Jose Belderbos,et al.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Alfons G H Kessels,et al.  Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Jan-Jakob Sonke,et al.  Adaptive radiotherapy for lung cancer. , 2010, Seminars in radiation oncology.

[17]  D. Lacombe,et al.  EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  D. de Ruysscher,et al.  Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study. , 2010, International journal of radiation oncology, biology, physics.

[19]  Philippe Lambin,et al.  Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Radhe Mohan,et al.  Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[21]  Ke Sheng,et al.  Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[22]  Joseph O Deasy,et al.  Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects. , 2010, International journal of radiation oncology, biology, physics.

[23]  Joseph O Deasy,et al.  The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. , 2010, International journal of radiation oncology, biology, physics.

[24]  Adam P Dicker,et al.  Radiation dose-volume effects in the brain. , 2010, International journal of radiation oncology, biology, physics.

[25]  Joseph O. Deasy,et al.  Radiation dose-volume effects in the esophagus. , 2010, International journal of radiation oncology, biology, physics.

[26]  K. Brock,et al.  Accurate accumulation of dose for improved understanding of radiation effects in normal tissue. , 2010, International Journal of Radiation Oncology, Biology, Physics.

[27]  Joseph O Deasy,et al.  Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.

[28]  M. Martel,et al.  Radiation dose-volume effects in the lung. , 2010, International journal of radiation oncology, biology, physics.

[29]  E. Yorke,et al.  Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.

[30]  T. Schultheiss,et al.  Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.

[31]  L. Baddour,et al.  Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  Peter A S Johnstone,et al.  Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  Ursula Nestle,et al.  Nonrigid Versus Rigid Registration of Thoracic 18F-FDG PET and CT in Patients with Lung Cancer: An Intraindividual Comparison of Different Breathing Maneuvers , 2009, Journal of Nuclear Medicine.

[34]  Jan-Jakob Sonke,et al.  Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography. , 2009, International journal of radiation oncology, biology, physics.

[35]  S. Senan,et al.  Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  L. Goldman,et al.  ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) (European Respiratory Journal (2009) 34 (17-41)) , 2009 .

[37]  A. Grosu,et al.  How to use functional imaging information for radiotherapy planning. , 2009, European journal of cancer.

[38]  Jonathan G. Li,et al.  Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. , 2009, International journal of radiation oncology, biology, physics.

[39]  Jan-Jakob Sonke,et al.  Effects of respiration-induced density variations on dose distributions in radiotherapy of lung cancer. , 2009, International journal of radiation oncology, biology, physics.

[40]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  C. Villarreal-Garza,et al.  High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine after Induction with Gemcitabine and Carboplatin , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[42]  C. Reddy,et al.  Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  Colin G Orton,et al.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2009, Medical physics.

[44]  L. Goldman,et al.  ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) , 2009, European Respiratory Journal.

[45]  Jan-Jakob Sonke,et al.  Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. , 2009, International journal of radiation oncology, biology, physics.

[46]  Shipeng Yu,et al.  The importance of patient characteristics for the prediction of radiation-induced lung toxicity. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  Elinore Wieslander,et al.  The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  Jan Nyman,et al.  Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[49]  Yuta Shibamoto,et al.  Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results , 2009, Radiation oncology.

[50]  Wolfgang A Weber,et al.  Assessing Tumor Response to Therapy , 2009, Journal of Nuclear Medicine.

[51]  Suresh Senan,et al.  Radiotherapy for lung cancer: clinical impact of recent technical advances. , 2009, Lung cancer.

[52]  Jane Higgins,et al.  Comparison of spine, carina, and tumor as registration landmarks for volumetric image-guided lung radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[53]  S. Senan,et al.  Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy , 2009, Cancer.

[54]  Joachim Widder,et al.  Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study , 2009, Radiation oncology.

[55]  S. Ben-Haim,et al.  18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response* , 2008, Journal of Nuclear Medicine.

[56]  Suresh Senan,et al.  Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies. , 2008, International journal of radiation oncology, biology, physics.

[57]  J. Galvin,et al.  Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[58]  D. Hellwig,et al.  FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer , 2009, Nuklearmedizin.

[59]  Cynthia S. Johnson,et al.  Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  Carri K Glide-Hurst,et al.  A simplified method of four-dimensional dose accumulation using the mean patient density representation. , 2008, Medical physics.

[61]  E. Kunieda,et al.  Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing , 2008, Radiation Medicine.

[62]  Lawrence B Marks,et al.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.

[63]  C. Yiannoutsos,et al.  Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[64]  B. Jeremic,et al.  Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC). , 2008, International journal of radiation oncology, biology, physics.

[65]  P. Lambin,et al.  Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non-small cell lung cancer (NSCLC): implications for clinical implementation in an individualized dose-escalation protocol. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  W. Oyen,et al.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[67]  C. Hurkmans,et al.  Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose , 2008, Radiation oncology.

[68]  T. Teshima,et al.  Changes in patterns of care for limited-stage small-cell lung cancer: results of the 99-01 patterns of care study-a nationwide survey in Japan. , 2008, International journal of radiation oncology, biology, physics.

[69]  J. Crowley,et al.  Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  P. Lambin,et al.  HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[71]  Geoffrey G. Zhang,et al.  Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. , 2008, International journal of radiation oncology, biology, physics.

[72]  James Bedford,et al.  Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[73]  Jan-Jakob Sonke,et al.  Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients. , 2008, International journal of radiation oncology, biology, physics.

[74]  E. Smit,et al.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[75]  Geoffrey D Hugo,et al.  Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. , 2008, International journal of radiation oncology, biology, physics.

[76]  Peter C Levendag,et al.  Time dependence of intrafraction patient motion assessed by repeat stereoscopic imaging. , 2008, International journal of radiation oncology, biology, physics.

[77]  On-line image guidance for frameless stereotactic radiotherapy of lung malignancies by cone beam CT: Comparison between target localization and alignment on bony anatomy , 2008, Acta oncologica.

[78]  P. Lambin,et al.  Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[79]  Radiation oncology advances: an introduction. , 2008, Cancer treatment and research.

[80]  Tommy Knöös,et al.  Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[81]  Marjan A Admiraal,et al.  Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  S. Ryu,et al.  Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTV. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[83]  Wei Lu,et al.  Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four-dimensional CT. , 2007, International journal of radiation oncology, biology, physics.

[84]  T. Krieger,et al.  Four-dimensional treatment planning for stereotactic body radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[85]  P. Lambin,et al.  Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials. , 2007, Cancer treatment reviews.

[86]  K. Ohtomo,et al.  Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors , 2007, Radiation oncology.

[87]  Jan-Jakob Sonke,et al.  Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. , 2007, International journal of radiation oncology, biology, physics.

[88]  George Starkschall,et al.  Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[89]  P. Lambin,et al.  Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[90]  B. Jeremic,et al.  Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey. , 2007, Lung cancer.

[91]  David A Jaffray,et al.  Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. , 2007, International journal of radiation oncology, biology, physics.

[92]  Matthias Guckenberger,et al.  Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[93]  S. Senan,et al.  Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer? , 2007, International journal of radiation oncology, biology, physics.

[94]  E. Dieleman,et al.  Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. , 2007, International journal of radiation oncology, biology, physics.

[95]  Jinming Yu,et al.  Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[96]  George Starkschall,et al.  Assessment of lung tumor motion and setup uncertainties using implanted fiducials. , 2007, International journal of radiation oncology, biology, physics.

[97]  Current practice when treating lung cancer in Australasia. , 2007, Australasian radiology.

[98]  Luca Cozzi,et al.  Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations , 2006, Physics in medicine and biology.

[99]  Philippe Lambin,et al.  Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study. , 2006, International journal of radiation oncology, biology, physics.

[100]  Ursula Nestle,et al.  Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[101]  Lech Papiez,et al.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[102]  Steve B. Jiang,et al.  The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.

[103]  J. Lebesque,et al.  Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[104]  P. Lambin,et al.  Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[105]  B. Heijmen,et al.  Limitations of the planning organ at risk volume (PRV) concept. , 2006, International journal of radiation oncology, biology, physics.

[106]  N. Viñolas,et al.  Spanish patterns of care for 3D radiotherapy in non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[107]  Suresh Senan,et al.  4D imaging for target definition in stereotactic radiotherapy for lung cancer , 2006, Acta oncologica.

[108]  Matthias Guckenberger,et al.  Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors , 2006, Acta oncologica.

[109]  Hak Choy,et al.  Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer , 2006, Acta oncologica.

[110]  P C Levendag,et al.  Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results , 2006, Acta oncologica.

[111]  S. Marnitz,et al.  Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy , 2006, Clinical Cancer Research.

[112]  Philippe Lambin,et al.  An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[113]  G. Guyatt,et al.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.

[114]  Patrick A Kupelian,et al.  Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. , 2005, International journal of radiation oncology, biology, physics.

[115]  Suresh Senan,et al.  Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[116]  J. Daurès,et al.  Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[117]  Randall K Ten Haken,et al.  CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. , 2005, International journal of radiation oncology, biology, physics.

[118]  Philippe Lambin,et al.  Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. , 2005, International journal of radiation oncology, biology, physics.

[119]  Suresh Senan,et al.  Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. , 2005, International journal of radiation oncology, biology, physics.

[120]  C. Ling,et al.  Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma , 2005, Cancer.

[121]  M. Socinski,et al.  Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? , 2005, International journal of radiation oncology, biology, physics.

[122]  M. Herk Errors and margins in radiotherapy. , 2004 .

[123]  J. Jett,et al.  The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[124]  M. Schwaiger,et al.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[125]  L. Broemeling,et al.  Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[126]  H. Groen,et al.  A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[127]  Danny Rischin,et al.  Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  Suresh Senan,et al.  Procedures for high precision setup verification and correction of lung cancer patients using CT-simulation and digitally reconstructed radiographs (DRR). , 2003, International journal of radiation oncology, biology, physics.

[129]  P. Voet,et al.  Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)? , 2002, Lung cancer.

[130]  N. Saijo,et al.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[131]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[132]  Marcel van Herk,et al.  Margins for geometric uncertainty around organs at risk in radiotherapy. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[133]  J. Herndon,et al.  Therapy choices among older patients with lung carcinoma , 2002, Cancer.

[134]  O. Holmberg,et al.  Impact of intravenous contrast on target definition in radiotherapy of non small cell lung cancer , 2001 .

[135]  R K Ten Haken,et al.  Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[136]  J C Rosenwald,et al.  Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.

[137]  S. Kudoh,et al.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  R. Ginsberg,et al.  Induction therapy for stage III NSCLC: a consensus report. , 1994, Lung cancer.

[139]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[140]  K M Harris,et al.  The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. , 1993, Clinical radiology.

[141]  S Sone,et al.  The number and size of normal mediastinal lymph nodes: a postmortem study. , 1988, AJR. American journal of roentgenology.

[142]  F L Bookstein,et al.  Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. , 1985, AJR. American journal of roentgenology.